Biogen Is Suffering From Doubts About the Future

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), KalVista Pharmaceuticals (KALV) and PTC Therapeutics (PTCT)

Analysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Recursion Pharmaceuticals (RXRX)

These stocks were oversold during this week's selloff and could be due for a bounce

SPY ETF Update, 4/4/2024? 

Biogen Inc. (BIIB) Falls More Steeply Than Broader Market: What Investors Need to Know

Biogen Inc. (BIIB) Falls More Steeply Than Broader Market: What Investors Need to Know

Buy Rating on Biogen: Focused on Leqembi’s IV Dosing Amidst SQ Formulation Delay

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT) and Biogen (BIIB)

Hold Rating on Biogen Amidst Leqembi’s Regulatory Challenges and Competitive Pressures

Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback

CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug

CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug

Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know

Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know

Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?

Truist Financial Reaffirms Their Buy Rating on Biogen (BIIB)

Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test

EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes